NEUP (STOCKS)

    Neuphoria Therapeutics Inc. Common Stock

    $4.070000
    +0.070000 (+1.75%)
    Prev close: $4.000000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Spyridon Papapetropoulos
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $21.89M
    Employees
    8
    P/E (TTM)
    -0.17
    P/B (TTM)
    0.76
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    2
    Strong Buy
    5
    Buy
    2
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Sep 2025 (Q1)
    $-4.41 $-1.35 -3.0568 -225.89%
    Jun 2025 (Q4)
    $-5.79 $-2.12 -3.6718 -173.35%